PROTALIX BIOTHERAPEUTICS, INC. (PLX)

[king oil]

You raise very plausible points. I hadn't thought of the recent uptick in violence as a potential factor. Perhaps they should consider either opening a second facility or moving the research facility to a safer location as a hedge against local conditions.

There also seems to be a lack of any recent analyst coverage. HC Wainwright issued a $4 price target back in September but I'm not aware of any updated forecast.

https://www.smarteranalyst.com/brief/h-c-wainwright-reiterates-their-buy-rating-on-protalix-biotherapeutics-plx/

This company needs to do more outreach to analysts and generate more coverage to counteract the CC Abbott effect. Investor relations is practically non-existent. I've sent several questions to that dept. with no response. That's certainly not confidence-inspiring to say the least.